EFFECTS OF MUTATIONS IN COLLAGEN GENES ON CARTILAGE MATRIX
EFFECTS OF MUTATIONS IN COLLAGEN GENES ON CARTILAGE MATRIX
批准号:
6592109
负责人:
SERGIO A JIMENEZ
金额:
$15.53万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-10 至 2007-03-31
关键词:
articular cartilage chemical kinetics chondrocytes chondrodystrophy collagen connective tissue development extracellular matrix proteins gene expression gene mutation genetically modified animals human fetus tissue immunocytochemistry immunoelectron microscopy laboratory mouse molecular assembly /self assembly osteoarthritis procollagen protein biosynthesis protein structure protein structure function tissue /cell culture transfection
中文摘要
本项目是上一个计划项目的项目3和项目4的合并。这个项目的主要目标将是建立一个详细的机制了解两个软骨特异性胶原基因(COL2A和COL9A2)的不同突变是如何导致软骨发育不良和早产性骨关节炎的。目的是利用体外和体内系统,全面了解这些突变对软骨基质的生化和结构的影响,对胚胎骨骼和关节发育的影响,最终对成人关节软骨的影响。为了实现这一目标,我们将开发我们在之前的资助期间开发的聚甲基丙烯酸羟乙酯(Poly-HEMA)软骨细胞培养系统,该系统允许长期保存软骨细胞的软骨特有表型。其次,我们将建立基因敲除小鼠的品系,这些小鼠具有软骨特有的胶原基因突变,这些基因突变会导致人类软骨发育不良和早产性骨关节炎。第三,我们将创建转基因小鼠系,在其中突变的胶原分子可以以软骨特异的和有条件的方式表达。由此产生的动物品系将通过形态、组织学和组织病理学评估进行详细检查,并将提供给我们的合作者和其他研究人员,以研究体内突变的功能影响。此外,这些小鼠的关节软骨将使用高度敏感的渗透加载方法进行生物力学检查,以回答突变对组织生物材料特性的功能影响,并试图建立可能与骨关节炎的发病机制直接相关的结构/功能关系。第四,我们将利用纯化的胶原分子以及体外纤维形成和蛋白质相互作用分析来更好地了解这些突变对胶原单体结构、纤维组装和结构的影响,以及II型和IX型胶原之间的分子相互作用。这个项目的总体目标将通过追求以下具体目标来实现:(1)确定突变的细胞外基质基因的表达对培养的软骨细胞表型的影响以及由此产生的软骨基质的功能特征;(2)通过在相应的小鼠基因中引入(敲入)类似的人类突变,建立真正的人类COL2A1和COL9A2基因突变引起的人类慢性软骨发育不良的小鼠模型;(3)确定突变胶原蛋白在成年小鼠关节中的条件性组织特异性表达的影响;(4)研究Arg75、Arg519和Arg789对II型胶原Cys突变对胶原纤维组装的影响,以及野生型和突变型II型胶原与I型胶原之间的相互作用。
英文摘要
This project is a consolidation of Project 3 and Project 4 of the previous Program Project. The major goal of this project will be to establish a detailed mechanistic understanding of how different mutations in two cartilage-specific collagen genes (COL2A and COL9A2) result in chondrodysplasia and premature OA. The aim will be to utilize in vitro and in vivo systems to gain a full understanding of the effects of these mutations on the biochemistry and structure of the cartilage matrix, on embryonic skeletal and joint development and finally on adult articular cartilage. To achieve this, we will exploit the poly 2-hydroxyethyl methacrylate (poly-HEMA) chondrocyte culture system we developed during the previous funding periods which allows the long-term preservation of the cartilage-specific phenotype of chondrocytes. Second, we will establish lines of knock-in mice that harbor the same mutations in cartilage-specific collagen genes that cause chondrodysplasia and premature OA in humans. Third, we will create transgenic mouse lines in which the mutated collagen molecules can be expressed in a cartilage specific and conditional manner. The resulting animal lines will be examined in detail employing morphologic, histologic, and histopathological assessments and will be made available to our collaborators and to other investigators to study the functional effects of the mutations in vivo. Furthermore, articular cartilage from these mice will be examined biomechanically employing a highly sensitive osmotic loading method to answer the functional impact of the mutations on the biomaterial properties of the tissue and attempt to establish structure/function relationships that may be of direct relevance to the pathogenesis of osteoarthritis. Fourth, we will utilize purified collagen molecules and in vitro fibril formation and protein interaction assays to obtain a better understanding of the effects of these mutations on collagen monomer structure, fibril assembly and structure, and molecular interactions between collagens II and IX. The overall goal of this project will be achieved by pursuing the following Specific Aims: (1) To determine the effects of expression of mutated extracellular matrix genes on the phenotype of chondrocytes in culture and the functional characteristics of the resulting cartilaginous matrix; (2) To generate authentic mouse models of the human chrondrodysplasias caused by mutations in the human COL2A1 and COL9A2 genes by introducing (knocking-in) the analogous human mutations in the corresponding mouse genes; (3) To determine the effects of conditional tissue-specific expression of mutant collagens in the articular of adult mice; and (4) To study the effects of Arg75, Arg519 and Arg789 to Cys mutations in type II collagen on collagen fibril assembly and to study interactions between wild type and mutant collagen II and collagen IX.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Serum Exosome MicroRNA in Systemic Sclerosis
-
批准号:9299047
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2017
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy
-
批准号:8702580
-
项目类别:
-
资助金额:$20.46万
-
财政年份:2014
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy
-
批准号:9034722
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2014
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy
-
批准号:8826028
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2014
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of toll like receptors (TLRs)in Gd contrast agent induced skin fibrosis
-
批准号:8549103
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2012
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of toll like receptors (TLRs)in Gd contrast agent induced skin fibrosis
-
批准号:8301981
-
项目类别:
-
资助金额:$17.44万
-
财政年份:2012
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Identification of Novel Markers for Systemic Sclerosis Employing Proteomics
-
批准号:8125088
-
项目类别:
-
资助金额:$20.09万
-
财政年份:2010
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Identification of Novel Markers for Systemic Sclerosis Employing Proteomics
-
批准号:7979478
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2010
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
-
批准号:8078005
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2008
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
-
批准号:8270386
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2008
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
-
批准号:7533226
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2008
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
-
批准号:7645635
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2008
-
负责人:SERGIO A JIMENEZ
-
依托单位:
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy
-
批准号:7846849
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2008
-
负责人:SERGIO A JIMENEZ
-
依托单位:
EFFECTS OF MUTATIONS IN COLLAGEN AND COMP GENES ON CARTILAGE MATRIX
-
批准号:6299831
-
项目类别:
-
资助金额:$15.53万
-
财政年份:2000
-
负责人:SERGIO A JIMENEZ
-
依托单位:
EFFECTS OF MUTATIONS IN COLLAGEN AND COMP GENES ON CARTILAGE MATRIX
-
批准号:6100488
-
项目类别:
-
资助金额:$15.53万
-
财政年份:1999
-
负责人:SERGIO A JIMENEZ
-
依托单位:
EFFECTS OF MUTATIONS IN COLLAGEN AND COMP GENES ON CARTILAGE MATRIX
-
批准号:6268367
-
项目类别:
-
资助金额:$14.22万
-
财政年份:1998
-
负责人:SERGIO A JIMENEZ
-
依托单位:
EFFECTS OF MUTATIONS IN COLLAGEN AND COMP GENES ON CARTILAGE MATRIX
-
批准号:6235742
-
项目类别:
-
资助金额:$14.15万
-
财政年份:1997
-
负责人:SERGIO A JIMENEZ
-
依托单位:
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS
-
批准号:6171641
-
项目类别:
-
资助金额:$15.36万
-
财政年份:1994
-
负责人:SERGIO A JIMENEZ
-
依托单位:
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS
-
批准号:7068132
-
项目类别:
-
资助金额:$15.94万
-
财政年份:1994
-
负责人:SERGIO A JIMENEZ
-
依托单位:
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS
-
批准号:6884885
-
项目类别:
-
资助金额:$17.13万
-
财政年份:1994
-
负责人:SERGIO A JIMENEZ
-
依托单位:
海外基金